The present invention relates to compounds capable of inhibiting p38a-Kinase, to pharmaceutical compositions comprising these compounds, and to methods of using the compounds for the treatment or prevention of diseases or disorders that are mediated by p38-a Kinase, particularly for the treatment or prevention of inflammatory diseases and disorders and heart conditions.
展开▼
